AR029334A1 - Uso de derivados anti-convulsivos para la manufactura de un medicamento para el tratamiento del autismo - Google Patents
Uso de derivados anti-convulsivos para la manufactura de un medicamento para el tratamiento del autismoInfo
- Publication number
- AR029334A1 AR029334A1 ARP000100525A ARP000100525A AR029334A1 AR 029334 A1 AR029334 A1 AR 029334A1 AR P000100525 A ARP000100525 A AR P000100525A AR P000100525 A ARP000100525 A AR P000100525A AR 029334 A1 AR029334 A1 AR 029334A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture
- autism
- derivatives
- alkyl
- convulsive
- Prior art date
Links
- 206010003805 Autism Diseases 0.000 title abstract 2
- 208000020706 Autistic disease Diseases 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 230000002082 anti-convulsion Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 239000001301 oxygen Chemical group 0.000 abstract 2
- 229910052760 oxygen Chemical group 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001336 alkenes Chemical class 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 methylenedioxy group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11910499P | 1999-02-08 | 1999-02-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR029334A1 true AR029334A1 (es) | 2003-06-25 |
Family
ID=22382571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000100525A AR029334A1 (es) | 1999-02-08 | 2000-02-07 | Uso de derivados anti-convulsivos para la manufactura de un medicamento para el tratamiento del autismo |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6552000B2 (enExample) |
| EP (1) | EP1152756B1 (enExample) |
| JP (1) | JP2002536328A (enExample) |
| AR (1) | AR029334A1 (enExample) |
| AT (1) | ATE299371T1 (enExample) |
| AU (1) | AU763601B2 (enExample) |
| CA (1) | CA2361584C (enExample) |
| DE (1) | DE60021252T2 (enExample) |
| DK (1) | DK1152756T3 (enExample) |
| ES (1) | ES2244411T3 (enExample) |
| MX (1) | MXPA01008038A (enExample) |
| PT (1) | PT1152756E (enExample) |
| TR (1) | TR200103125T2 (enExample) |
| WO (1) | WO2000045812A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060020037A1 (en) * | 2004-07-22 | 2006-01-26 | Allergan, Inc. | Tazarotenic acid and esters thereof for treating autism |
| US9095713B2 (en) * | 2004-12-21 | 2015-08-04 | Allison M. Foster | Methods and systems for treating autism by decreasing neural activity within the brain |
| US9327069B2 (en) * | 2004-12-21 | 2016-05-03 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating a medical condition by promoting neural remodeling within the brain |
| US20070038264A1 (en) * | 2004-12-21 | 2007-02-15 | Jaax Kristen N | Methods and systems for treating autism |
| US20070034214A1 (en) * | 2005-08-12 | 2007-02-15 | Dochniak Michael J | Method to affect the development of autism spectrum disorders |
| US20090076128A1 (en) * | 2007-09-15 | 2009-03-19 | Protia Llc | Deuterium-enriched topiramate |
| WO2016022324A1 (en) * | 2014-05-30 | 2016-02-11 | The Children's Hospital Of Philadelphia | Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| US11219617B2 (en) | 2014-05-30 | 2022-01-11 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating autism |
| CA3037858A1 (en) | 2016-09-21 | 2018-03-29 | JC Pharma, Inc. | Method and composition for acute treatment of seizures |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US5753693A (en) | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder |
| US6020310A (en) * | 1997-05-19 | 2000-02-01 | Repligen Corporation | Method for assisting in differential diagnosis and treatment of autistic syndromes |
-
2000
- 2000-01-18 DK DK00904390T patent/DK1152756T3/da active
- 2000-01-18 TR TR2001/03125T patent/TR200103125T2/xx unknown
- 2000-01-18 EP EP00904390A patent/EP1152756B1/en not_active Expired - Lifetime
- 2000-01-18 CA CA002361584A patent/CA2361584C/en not_active Expired - Fee Related
- 2000-01-18 US US09/484,522 patent/US6552000B2/en not_active Expired - Fee Related
- 2000-01-18 JP JP2000596932A patent/JP2002536328A/ja not_active Withdrawn
- 2000-01-18 DE DE60021252T patent/DE60021252T2/de not_active Expired - Fee Related
- 2000-01-18 WO PCT/US2000/001127 patent/WO2000045812A1/en not_active Ceased
- 2000-01-18 ES ES00904390T patent/ES2244411T3/es not_active Expired - Lifetime
- 2000-01-18 PT PT00904390T patent/PT1152756E/pt unknown
- 2000-01-18 AU AU26156/00A patent/AU763601B2/en not_active Ceased
- 2000-01-18 MX MXPA01008038A patent/MXPA01008038A/es active IP Right Grant
- 2000-01-18 AT AT00904390T patent/ATE299371T1/de not_active IP Right Cessation
- 2000-02-07 AR ARP000100525A patent/AR029334A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU763601B2 (en) | 2003-07-31 |
| TR200103125T2 (tr) | 2002-04-22 |
| EP1152756B1 (en) | 2005-07-13 |
| EP1152756A1 (en) | 2001-11-14 |
| US6552000B2 (en) | 2003-04-22 |
| MXPA01008038A (es) | 2002-04-24 |
| DE60021252T2 (de) | 2006-05-18 |
| DK1152756T3 (da) | 2005-10-10 |
| WO2000045812A1 (en) | 2000-08-10 |
| US20020035068A1 (en) | 2002-03-21 |
| PT1152756E (pt) | 2005-09-30 |
| ES2244411T3 (es) | 2005-12-16 |
| DE60021252D1 (de) | 2005-08-18 |
| ATE299371T1 (de) | 2005-07-15 |
| AU2615600A (en) | 2000-08-25 |
| CA2361584C (en) | 2005-06-14 |
| CA2361584A1 (en) | 2000-08-10 |
| JP2002536328A (ja) | 2002-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032465A1 (es) | Derivados anticonvulsivos utiles para la preparacion de un medicamento para prevenir el desarrollo de la diabetes mellitus de tipo ii y del sindrome x | |
| WO2000061138A8 (en) | Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders | |
| WO2000061139A8 (en) | Anticonvulsant derivatives useful in reducing blood glucose levels | |
| DE3783988D1 (de) | Zyklische enolderivate, herstellung und anwendung. | |
| AR029334A1 (es) | Uso de derivados anti-convulsivos para la manufactura de un medicamento para el tratamiento del autismo | |
| ATE94384T1 (de) | Verwendung von adamantan-derivaten zur praevention und behandlung der cerebralen ischaemie. | |
| SE9702564D0 (sv) | New compounds | |
| CA2369093A1 (en) | Anticonvulsant derivatives useful in lowering lipids | |
| MX9803753A (es) | Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos. | |
| CA2369091A1 (en) | Anticonvulsant derivatives useful in lowering blood pressure | |
| DE69034226D1 (de) | Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu | |
| AP1513A (en) | Anti-convulsant derivatives useful in treating neuropathic pain. | |
| ATE235901T1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen | |
| AR035451A1 (es) | Derivados de beta-carbolina, su uso para la fabricacion de un medicamento para el tratamiento de la depresion, ansiedad y desordenes bipolares, una composicion farmaceutica y una combinacion. | |
| DE69330272D1 (de) | 4-imidomethyl-1-[2'-phenyl-2-oxoethyl]-piperidine als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung | |
| SE9702563D0 (sv) | Compounds | |
| AR029331A1 (es) | Uso de derivados anticonvulsivos para la manufactura de un medicamento en el tratamiento de la bulimia nerviosa | |
| AR034088A1 (es) | Composicion que comprende derivados anticonvulsivantes utiles en el tratamiento de esquizofrenia y el uso de dicho derivado para la manufactura de un medicamento | |
| UA41329C2 (uk) | Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії | |
| NZ333587A (en) | Topiramate derivatives useful in treating psoriasis | |
| YU17999A (sh) | Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu | |
| WO2000023059A3 (en) | Use of anticonvulsant derivatives for treating alcohol dependency | |
| NZ332029A (en) | Sulfonamide substituted chromans, process for their preparation, their use as a medicament and pharmaceutical preparations comprising them | |
| ATE181503T1 (de) | Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution | |
| BR0107211A (pt) | Agente para tratar hepatite c |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |